nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—prostate cancer—penile cancer	0.97	1	CtDrD
Bicalutamide—AR—scrotum—penile cancer	0.0183	0.612	CbGeAlD
Bicalutamide—AR—penis—penile cancer	0.00824	0.276	CbGeAlD
Bicalutamide—AR—skin of body—penile cancer	0.00138	0.0461	CbGeAlD
Bicalutamide—AR—urethra—penile cancer	0.00132	0.0442	CbGeAlD
Bicalutamide—AR—lymph node—penile cancer	0.000628	0.0211	CbGeAlD
